Axogen, Inc. SEC filings AXGN

Axogen, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Aug 15, 2014. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 28, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

Axogen, Inc. SEC filings
Form Description Filed Period
DEF 14A Proxy statement Apr 29, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 30, 2025 Jun 18, 2025
DEF 14A Proxy statement Apr 24, 2024 Jun 5, 2024
PRE 14A Preliminary proxy statement Apr 4, 2024 Jun 5, 2024
DEF 14A Proxy statement Jul 7, 2023 Dec 31, 2022
PRE 14A Preliminary proxy statement Jun 21, 2023 Aug 15, 2023
DEF 14A Proxy statement Apr 14, 2022 Dec 31, 2021
PRE 14A Preliminary proxy statement Apr 4, 2022 Dec 31, 2021
DEF 14A Proxy statement Mar 31, 2021 Dec 31, 2020
DEF 14A Proxy statement Apr 17, 2020 May 28, 2020
DEF 14A Proxy statement Jun 27, 2019 Aug 14, 2019
DEFA14A Additional proxy material Mar 30, 2018 —
DEFA14A Additional proxy material Mar 30, 2018 —
DEF 14A Proxy statement Mar 29, 2018 May 14, 2018
PRE 14A Preliminary proxy statement Mar 15, 2018 May 14, 2018
DEF 14A Proxy statement Apr 7, 2017 May 24, 2017
DEF 14A Proxy statement Apr 8, 2016 May 26, 2016
DEF 14A Proxy statement Apr 15, 2015 May 28, 2015

Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
AXGN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
MN
Headquarters
Alachua, FL
SEC filer status
Large accelerated filer
SEC CIK
805928
Former names
LECTEC CORP /MN/ (until Sep 29, 2011)

Other Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.